Farewell Collection
NDC Package 81892-115-11

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Farewell Collection is apply on skin thoroughly, wash, and rinse. Marketed by Paveemol Company Limited, this product is identified by NDC 81892-115 and is authorized under FDA application part333A.

Identification & Billing

NDC Package Code
81892-115-11
Package Description
250 mL in 1 BOTTLE, DISPENSING
Product Code
81892-115
11-Digit Billing Format
81892011511
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Farewell Collection
Dosage Form
-
Usage Information
Apply on skin thoroughly, wash, and rinse. Suitable to daily use.Supervise children under 6 years of age when using this product to avoid swallowing.

Regulatory & Marketing

Labeler Name
Paveemol Company Limited
FDA Application #
part333A
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
06-22-2021
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81892-115-11 identifies a specific commercial package of 250 ml in 1 bottle, dispensing of Farewell Collection, labeled by Paveemol Company Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Paveemol Company Limited on June 22, 2021. The current certification is valid through December 31, 2023.

How is this Paveemol Company Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81892011511. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81892-115-11
11-Digit CMS (5-4-2)
81892-0115-11

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.